01904nam a2200421 i 4500 289329 289329 on1123197063 OCoLC 20191206193106.0 m o d f cr bn||||||||| 191016s2019 dcu ob f000 0 eng c PUCPR eng rda pn GPO MvI pcc n-us--- 1043-C (online) Y 4.L 11/4:S.HRG.115-663 Y 4.L 11/4:S.HRG.115-663 United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, Gene editing technology : innovation and impact : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session, on examining gene editing technology, focusing on innovation and impact, November 14, 2017. Washington : U.S. Government Publishing Office, 2019. 1 online resource (iii, 54 pages). txt c rdamedia cr rdacarrier S. hrg. ; 115-663 CRDP Program record. Includes bibliographical references. Description based on online resource; title from PDF title page (govinfo, viewed on Oct. 16, 2019). Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Gene editing technology (OCoLC)1123194591 United States. Congress. Senate. S. hrg. ; 115-663. https://purl.fdlp.gov/GPO/gpo127143 KF26 .L27 2017w CRISPR-associated protein 9. Genetic engineering Technological innovations United States. Biotechnology Research United States. Legislative hearings. lcgft sudocs 8 0 0 sudocs 0 Y_4L_114SHRG115663 0 418265 7 7 55 2019-12-06 0 Y 4.L 11/4:S.HRG.115-663 Y 4.L (ONLINE VERSIO 2019-12-06 00:00:00 2019-12-06 8